What is the latest LALPATHLAB stock price?
The latest stored price for LALPATHLAB is Rs 2,000.70 as of 2026-11-16.
DR. LAL PATH LABS LTD. is a small-cap stock in Healthcare. This Gimli page shows the latest available LALPATHLAB price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for LALPATHLAB is Rs 2,000.70 as of 2026-11-16.
LALPATHLAB is above 50DMA, above 200DMA. The latest 50DMA is 1,928.35 and the latest 200DMA is 1,666.20.
LALPATHLAB has PE 56.82, ROE +24.58%, and ROCE +31.35% in Gimli's latest available snapshot.
LALPATHLAB has returned +7.57% over 1 month, +4.40% over 3 months, and +26.90% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 873.90 cr | 314.40 cr | 192.20 cr | 11.51 |
| 2026-06-30 | 797.70 cr | 279.40 cr | 169.50 cr | 10.15 |
| 2026-03-31 | 702.70 cr | 210.80 cr | 131.30 cr | 7.86 |
| 2025-12-31 | 659.80 cr | 173.60 cr | 90.50 cr | 5.42 |
| 2025-09-30 | 722.40 cr | 248.90 cr | 145.70 cr | 9.03 |
| 2025-06-30 | 669.80 cr | 220.40 cr | 132.40 cr | 7.94 |
| 2025-03-31 | 602.60 cr | 194.80 cr | 154.80 cr | 9.29 |
| 2024-12-31 | 596.70 cr | 179.10 cr | 96.70 cr | nan |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 2,760.31 cr | 836.42 cr | 508.21 cr | 30.24 |
| 2025-03-31 | 2,461.22 cr | 789.03 cr | 487.14 cr | 29.24 |
| 2024-03-31 | 2,226.50 cr | 678.41 cr | 357.74 cr | 21.52 |
| 2023-03-31 | 2,016.64 cr | 531.55 cr | 238.85 cr | 14.41 |
| 2022-03-31 | 2,087.40 cr | 613.20 cr | 344.80 cr | 20.85 |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 3,146.00 cr | 242.80 cr | 198.99 cr | 2,541.28 cr |
| 2025-03-31 | 2,716.79 cr | 292.63 cr | 157.43 cr | 2,206.48 cr |
| 2024-03-31 | 2,455.96 cr | 360.93 cr | 246.93 cr | 1,885.36 cr |
| 2023-03-31 | 2,385.56 cr | 263.73 cr | 419.50 cr | 1,699.55 cr |
| 2022-03-31 | 2,353.22 cr | 378.19 cr | 532.43 cr | 1,543.54 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 635.61 cr | 462.23 cr | n/a |
| 2025-03-31 | 568.88 cr | 515.01 cr | n/a |
| 2024-03-31 | 535.33 cr | 477.90 cr | n/a |
| 2023-03-31 | 456.03 cr | 411.46 cr | n/a |
| 2022-03-31 | 446.70 cr | -29.40 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-09-30 | +52.93% | +18.73% | +21.58% | +18.68% | +6.35% | +0.00% |
| 2026-06-30 | +53.19% | +17.36% | +21.59% | +18.79% | +7.47% | +0.00% |
| 2026-03-31 | +53.21% | +17.18% | +21.38% | +18.62% | +7.87% | +0.00% |
| 2025-12-31 | +53.21% | +20.29% | +19.21% | +16.84% | +6.94% | +0.00% |
| 2025-12-22 | +53.21% | +20.68% | +18.96% | +16.60% | +6.79% | +0.00% |
| 2025-09-30 | +53.21% | +21.86% | +18.49% | +15.90% | +6.07% | +0.00% |
| 2025-06-30 | +53.79% | +21.68% | +17.91% | +15.04% | +6.23% | +0.00% |
| 2025-03-31 | +53.91% | +23.91% | +16.08% | +12.84% | +5.84% | +0.00% |
| 2024-12-31 | +53.91% | +26.82% | +13.17% | +10.25% | +5.82% | +0.00% |
| 2024-09-30 | +53.92% | +26.82% | +12.89% | +9.84% | +6.04% | +0.00% |
| 2024-06-30 | +54.60% | +25.42% | +12.71% | +9.30% | +6.96% | +0.00% |
| 2024-03-31 | +54.60% | +26.15% | +9.69% | +6.79% | +9.24% | +0.00% |
| 2023-12-31 | +54.60% | +25.35% | +9.56% | +5.88% | +10.12% | +0.00% |
| 2023-09-30 | +54.61% | +24.36% | +9.14% | +5.36% | +11.48% | +0.00% |
| 2023-06-30 | +55.01% | +23.27% | +8.63% | +4.92% | +12.66% | +0.00% |
| 2023-03-31 | +55.03% | +24.89% | +6.55% | +3.26% | +13.01% | +0.00% |
| 2022-12-31 | +55.05% | +25.80% | +6.19% | +2.71% | +12.40% | +0.00% |
| 2022-09-30 | +55.05% | +23.26% | +6.27% | +2.76% | +14.85% | +0.00% |
| 2022-06-30 | +55.05% | +0.00% | +28.89% | n/a | n/a | +0.00% |
| 2022-03-31 | +55.23% | +0.00% | +30.27% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.